Enlivex Therapeutics Ltd (NASDAQ:ENLV)

1.54
Delayed Data
As of Sep 28
 0.00 / 0.00%
Today’s Change
1.36
Today|||52-Week Range
4.92
-60.89%
Year-to-Date

Stock Price Forecast

The 1 analysts offering 12-month price forecasts for Enlivex Therapeutics Ltd have a median target of 12.00, with a high estimate of 12.00 and a low estimate of 12.00. The median estimate represents a +679.22% increase from the last price of 1.54.

Analyst Recommendations

The current consensus among 1 polled investment analysts is to Buy stock in Enlivex Therapeutics Ltd. This rating has held steady since July, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
-$0.41
Sales
$0.00
Reporting Date
Nov 20

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly -10.81%
 
 
 
 
 
 
Growthannually -3.55%
 
 
 
 
 
 

Sales

Growthquarterly --
Growthannually --
Key to the earnings and sales forecast charts.